Connor, Clark & Lunn Investment Management »

Kura Oncology shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Kura Oncology (KURA) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Kura Oncology

Tip: Access up to 7 years of quarterly data

All positions including Kura Oncology held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kura Oncology by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2M 365k 8.85
2024-09-30 $580k 30k 19.54
2024-06-30 $452k 22k 20.59
2023-12-31 $272k 19k 14.38
2022-09-30 $727k 53k 13.66

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Cibc Cad (CM)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Microsoft Corporation (MSFT)
Bk Nova Cad (BNS)
Apple (AAPL)
Tc Energy Corp (TRP)
Suncor Energy (SU)
Celestica (CLS)
Amazon (AMZN)
Enbridge (ENB)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Kura Oncology

BlackRock
BVF
Suvretta Capital Management
Vanguard Group
Armistice Capital
State Street Corporation
Prosight Management
Goldman Sachs Group
AQR Capital Management
Jacobs Levy Equity Management
Millennium Management
Geode Capital Management
Morgan Stanley
Qube Research & Technologies
Alethea Capital Management

View all funds holding Kura Oncology